PMV Pharma

IPO

Harnessing the Power of p53 to treat Cancer

Public · Princeton, United States · Founded 2013 · $206.0M raised

Employees
11–50
Founded
2013
Business Model
B2B
Total Funding
$206.0M
Last Round
$70.0M Series DAug 2020
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

PMV Pharmaceuticals (PMV Pharma) is a clinical-stage precision oncology company founded in 2013 in Princeton, New Jersey. The company's platform targets p53, the most commonly mutated tumor suppressor protein in human cancer, with the goal of developing mutation-specific therapies. PMV's lead candidate, rezatapopt (PC14586), is a first-in-class small molecule designed to selectively reactivate the TP53 Y220C mutation across advanced solid tumors, currently in Phase 2 clinical trials (PYNNACLE study). The company was co-founded by renowned p53 biologist Arnold Levine, Ph.D., who discovered the p53 protein in 1979, along with David Mack, Ph.D. and Thomas Shenk, Ph.D. PMV went public on NASDAQ under the ticker PMVP.

Summary

PMV Pharma is a Biotech company based in Princeton, United States, founded in 2013. It has raised $206.0M in total across 3 rounds, most recently a $70.0M Series D round in Aug 2020. Investors include Nextech Invest, Avoro Ventures and Viking Global.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOSep 2020
$243.5M

Sign up to see all 4 events

Funding: Series B through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$2.1BJun 2026
PacBioIPO

Developer and manufacturer of high-accuracy long-read DNA sequencing systems and consumables for ...

USA, United States501–1000Biotech, Genomics
ConvertibleTotal funding$1.2BFeb 2021
Ultima Genomics

Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...

Fremont, United States201–500Artificial Intelligence, Healthcare
Series ETotal funding$1.1BJun 2022
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Element Biosciences

Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...

San Diego, United States201–500Biotech, Genomics
Series ETotal funding$853.3MJun 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

PMV Pharma on Indexed.vc
<a href="https://indexed.vc/companies/pmv-pharma"><img src="https://indexed.vc/api/badge/company/pmv-pharma" alt="PMV Pharma on Indexed.vc" width="260" height="76" /></a>